Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United States Journal Article


Authors: Rondeau, G.; Tuttle, R. M.
Article Title: Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United States
Abstract: The management of thyroid cancer has become more refined and complex over the last thirty years. In an effort to provide guidance to both clinicians and patients, several organizations have developed clinical management guidelines that provide specific advice regarding the diagnosis, treatment and follow-up of differentiated thyroid cancer. In this review, we compare and contrast the major management recommendations provided in the guidelines of the European Thyroid Association with those published by thyroid cancer specialty organizations in the United States (American Thyroid Association and National Comprehensive Cancer Network). By carefully examining treatment and management approaches that are applied in other areas of the world, we can identify equally effective alternative treatment or follow-up options that may find applicability to specific patients in our own practice. Despite significant difference in cultures, economies, and health care delivery systems, thyroid cancer management recommendations from the European experts and the American experts are far more similar than they are different. Each of the guidelines strongly endorses an initial management approach that is guided by individualized estimates of risk of recurrence and risk of death. Furthermore, follow up and additional therapeutic recommendations are based on revised risk estimates that reflect an individual patient's response to therapy. © 2011 Published by Elsevier Inc.
Keywords: united states; cancer staging; positron emission tomography; follow up; clinical practice; practice guideline; risk factor; europe; iodine 131; echography; thyroidectomy; thyroid cancer; thyroglobulin; thyroid follicle cell; health care delivery; recombinant thyrotropin; fluorodeoxyglucose
Journal Title: Seminars in Nuclear Medicine
Volume: 41
Issue: 2
ISSN: 0001-2998
Publisher: Elsevier Inc.  
Date Published: 2011-03-01
Start Page: 89
End Page: 95
Language: English
DOI: 10.1053/j.semnuclmed.2010.10.001
PROVIDER: scopus
PUBMED: 21272682
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 4 March 2011" - "CODEN: SMNMA" - "Source: Scopus"
Altmetric
Citation Impact
MSK Authors
  1. Robert M Tuttle
    395 Tuttle